Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

Clinical trial NCT01949532 · COMPLETED

Trial details

NCT number: NCT01949532
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Multiple Myeloma End-stage Renal Disease

Start date: 2014-01-01
Primary completion: 2015-04-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.